ADPT
Adaptive Biotechnologies Corporation · Healthcare · Biotechnology
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -11.5% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 18.90K | $493,205 | n/a | −2 |
| Q2 2026 | 106 | 0 | 115.12M | $2.47B | +6 | −7 |
| Q1 2026 | 110 | +7 | 111.61M | $1.55B | +11 | −4 |
| Q4 2025 | 102 | 0 | 114.72M | $1.86B | +1 | −1 |
| Q3 2025 | 21 | +2 | 74.70M | $1.12B | +2 | n/a |
| Q2 2025 | 16 | +2 | 70.34M | $819.50M | +2 | n/a |
| Q1 2025 | 11 | 0 | 46.91M | $348.49M | +2 | −2 |
| Q4 2024 | 11 | -1 | 53.01M | $317.80M | n/a | −1 |
| Q3 2024 | 11 | +2 | 55.08M | $282.02M | +2 | n/a |
| Q2 2024 | 9 | n/a | 54.39M | $196.88M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investors ✦ | 29.99M | 0.0% | $222.85M | 0.7% | Held | 4 | SEC ↗ |
| 2 | ARK Investment Management ✦ | 7.73M | -17.9% | $57.45M | 0.6% | ▼ Trim | 4 | SEC ↗ |
| 3 | Millennium Management ✦ | 3.00M | -52.4% | $22.26M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 2.78M | +3.6% | $20.67M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (passive) | 2.69M | -1.5% | $19.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 310.27K | +45.8% | $2.26M | 0.0% | ▲ Add | 4 | SEC ↗ ×5 |
| 7 | Citadel Advisors ✦ | 144.34K | -36.4% | $1.07M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 105.89K | -53.9% | $786,726 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 99.46K | +5.9% | $740,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Arrowstreet Capital ✦ | 45.74K | New | $339,856 | 0.0% | New | 1 | SEC ↗ |
| 11 | Gotham Asset Management ✦ | 10.69K | New | $79,449 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $339,856 | 0.0% |
| Gotham Asset Management | $79,449 | 0.0% |
Exited
| Point72 Asset Management | $5.62M | was 0.0% |
| Two Sigma Investments | $1.10M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 295 holders, 151.59M shares, $2.01B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 5.88K sh · $150,403
Officer · 6.00K sh · $151,475
Officer · 100 sh · $2,485
Officer · 11.78K sh · $288,988
Officer · 11.88K sh · $285,738
Officer · 11.58K sh · $280,376
Officer · 300 sh · $7,635
Officer · 11.88K sh · $304,272
Officer · 5.10K sh · $131,682
Officer · 6.78K sh · $173,390
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology